Recursion Pharmaceuticals Inc (RXRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Recursion Pharmaceuticals Inc-Aktie (RXRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	18.51% 7.67	6.472	35.54	5.175	19.22
Cost Of Revenue	8.00% 11.49	12.49	14.28	14.69	20.16
Research and Development	1.95% 89.61	87.90	-	-	-
Costs And Expenses	5.68% 142.64	134.98	143.87	177.38	195.45
Operating Income/Loss	5.03% -134.97	-128.50	-108.33	-172.20	-176.23
Nonoperating Income/Loss	38.06% 3.962	6.397	0.232	9.952	4.33
Income/Loss From Continuing Operations Before Tax	7.29% -131.01	-122.11	-108.10	-162.25	-171.90
Income Tax Expense/Benefit, Deferred	99.93% -0.003	-4.597	-	-	-
Income Tax Expense/Benefit	99.98% -0.001	-4.604	0.02	0.003	-
Net Income/Loss	11.49% -131.00	-117.50	-108.12	-162.25	-171.90
Basic Average Shares	0.60% 532.46	529.30	24.80	446.99	417.36
Diluted Average Shares	0.60% 532.46	529.30	24.80	446.99	417.36
Basic Earnings Per Share	13.64% -0.25	-0.22	-0.17	-0.36	-0.41
Diluted Earnings Per Share	13.64% -0.25	-0.22	-0.17	-0.36	-0.41